Biodefence Market is projected to grow at a CAGR of 7.78% by 2033: Visiongain Reports Ltd
January 16, 2023 10:11 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Biodefence Market 2023-2033. It includes profiles of Biodefence Market and Forecasts, Market Segment by Size by Product (Vaccines {Anthrax, Smallpox,...
Biodefense Market Research Report by Product, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
December 29, 2022 07:19 ET
|
ReportLinker
New York, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biodefense Market Research Report by Product, End User, Region - Global Forecast to 2027 -...
SENATE POLL: Tim Ryan Leads J.D. Vance 48% to 39% in Ohio
September 07, 2022 08:30 ET
|
Center Street PAC
Columbus, Ohio, Sept. 07, 2022 (GLOBE NEWSWIRE) -- A new poll from nonpartisan political action committee Center Street PAC (www.centerstreetpac.com) shows Rep. Tim Ryan (D-OH) continues to lead...
Redwood Living Inc. Named a Winner of the Northeast Ohio Top Workplaces 2022 Award for Fifth Consecutive Year
June 28, 2022 17:05 ET
|
Redwood Living
Independence, Ohio, June 28, 2022 (GLOBE NEWSWIRE) -- Innovative developer and manager of single-story apartment homes, Redwood Living, Inc (Redwood), has been awarded a Top Workplaces 2022 honor by...
SPR Therapeutics Named a Top Workplace
June 26, 2022 11:00 ET
|
SPR Therapeutics, Inc.
CLEVELAND, June 26, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics has been awarded a Top Workplaces 2022 honor by cleveland.com and The Plain Dealer. The award is based on employee feedback gathered...
Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-Q Filing
May 23, 2022 16:05 ET
|
Statera Biopharma
FORT COLLINS, Colo., May 23, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune...
Statera Biopharma and Lay Sciences Inc. Announce Intent to Enter Strategic Partnership to License the Manufacturing Rights to Certain Lay Sciences IgY Products
May 13, 2022 07:30 ET
|
Statera Biopharma
FORT COLLINS, Colo., May 13, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune...
Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone
April 27, 2022 16:10 ET
|
Statera Biopharma
FORT COLLINS, Colo., April 27, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a leading biopharmaceutical company creating next-generation immune therapies that focus on...
Statera Biopharma Receives Notification Letter from Nasdaq Regarding Form 10-K Filing
April 22, 2022 17:26 ET
|
Statera Biopharma
FORT COLLINS, Colo., April 22, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune...
Statera Biopharma and Coeptis Therapeutics Announce Strategic Agreement for Rights to Entolimod
April 13, 2022 16:05 ET
|
Statera Biopharma
FORT COLLINS, Colo., April 13, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune...